Miami, FL, United States of America

Solale Tabarestani

This inventor holds 2 USPTO granted patents. Top assignee: Florida International University. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Solale Tabarestani: Innovator in Alzheimer's Disease Visualization

Introduction

Solale Tabarestani is a prominent inventor based in Miami, FL, who has made significant contributions to the field of medical diagnostics. He holds 2 patents that focus on innovative systems and methods for aiding in the diagnosis and prognosis of Alzheimer's disease. His work is particularly relevant in the context of advancing healthcare technologies.

Latest Patents

Tabarestani's latest patents include systems and methods for color-coded visualization to aid in the diagnosis and prognosis of Alzheimer's disease. These systems utilize an integrated machine learning (ML) model that processes various inputs, such as neuroimaging data, neuropsychological test scores, cerebrospinal fluid biomarkers, and risk factors. The ML model generates a color-coded visualization of the disease state, enhancing the ability to diagnose and monitor Alzheimer's disease effectively.

Career Highlights

Solale Tabarestani is affiliated with Florida International University, where he contributes to research and development in the field of medical technology. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Some of his notable coworkers include Mohammad Eslami and Malek Adjouadi, who collaborate with him on various projects related to medical diagnostics and machine learning applications.

Conclusion

In summary, Solale Tabarestani is a key figure in the development of advanced diagnostic tools for Alzheimer's disease. His innovative work continues to pave the way for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…